XML 57 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 14 - Segment Information
 12 Months Ended
Mar. 31, 2015
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]

Note 14. Segment Data


We have three reporting segments: Biological Indicators, Instruments and Continuous Monitoring. The following tables set forth our segment information (in thousands):


   

Year Ended March 31, 2015

  
   

Biological

Indicators

    

Instruments

    

Continuous Monitoring

    

Total

  

Revenues

   $ 27,390     $ 33,054     $ 10,886     $ 71,330  
                                 

Gross profit

   $ 17,142     $ 20,763     $ 5,487     $ 43,392  

Selling expenses

     1,551       3,441       2,184       7,176  
    $ 15,591     $ 17,322     $ 3,303       36,216  

Reconciling items (1)

                             (20,869 )

Earnings before income taxes

                           $ 15,347  

   

Year Ended March 31, 2014

  
   

Biological

Indicators

    

Instruments

    

Continuous Monitoring

    

Total

  

Revenues

   $ 22,992     $ 26,389     $ 3,343     $ 52,724  
                                 

Gross profit

   $ 13,187     $ 16,904     $ 1,597     $ 31,688  

Selling expenses

     1,350       3,954       815       6,119  
    $ 11,837     $ 12,950     $ 782       25,569  

Reconciling items (1)

                             (12,466 )

Earnings before income taxes

                           $ 13,103  

   

Year Ended March 31, 2013

  
   

Biological

Indicators

    

Instruments

    

Continuous Monitoring

    

Total

  

Revenues

   $ 21,464     $ 24,971     $ --     $ 46,435  
                                 

Gross profit

   $ 12,365     $ 16,497     $ --     $ 28,862  

Selling expenses

     1,552       3,078       --       4,630  
    $ 10,813     $ 13,419     $ --       24,232  

Reconciling items (1)

                             (11,254 )

Earnings before income taxes

                           $ 12,978  

(1) Reconciling items include general and administrative, research and development, and other expenses.


Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):


   

Year Ended March 31,

  
   

2015

    

2014

    

2013

  

Revenues from unaffiliated customers

                        

United States

   $ 45,798     $ 29,551     $ 28,590  

Foreign

     25,532       23,173       17,845  
    $ 71,330     $ 52,724     $ 46,435  

   

March 31,

  
   

2015

    

2014

  

Total assets

                

Biological Indicators

   $ 36,304     $ 22,771  

Instruments

     44,401       36,797  

Continuous Monitoring

     31,558       28,578  

Corporate and administrative

     5,057       9,383  
    $ 117,320     $ 97,529  

All long-lived assets are located in the United States.